Exblifep’s approval was based on the ALLIUM study, which showed that the drug was superior to an older therapy based on piperacillin and tazobactam, achieving clinical cure and microbiological ...

The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

GSK stock is up 21.5% in six months, fueled by strong Specialty Medicines growth and a promising pipeline despite vaccine ...

As you get older, your estrogen starts to drop, but exactly when (and how quickly) varies from person to person. The average ...

NRx Pharmaceuticals (NASDAQ: NRXP) has filed for the newly launched FDA Commissioner's National Priority Voucher (CNPV) program, seeking accelerated ...

EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...